Here are five takeaways:
1. An aging population, increasing number of obesity cases and rising demand for minimally invasive surgery will spur market growth.
2. Unfavorable reimbursement policies will hinder market growth, however.
3. North America currently dominates the market, due to degenerative disc disease impacting about half of the U.S. population above 40 years old.
4. The Asia-Pacific region will see rapid growth because of its high population.
5. Dublin, Ireland-based Medtronic, Kalamazoo, Mich.-based Stryker Corp., Warsaw, Ind.-based Zimmer Biomet and West Chester, Pa.-based DePuy Synthes dominate the space.
More articles on devices:
Spineway’s capital boosts nearly $1.49M — 5 notes
Reconstructive knee replacement market to reach $5B by 2020 — 5 takeaways
System detects early stages of idiopathic scoliosis with 3D scans: 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
